The current valuation score of Century Therapeutics Inc is 8.66, ranking 75 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.82, which is -82.45% below the recent high of -0.32 and -1193.85% above the recent low of -23.49.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.